Australia's Lumos Diagnostics rises after positive Q2 results
** Shares of Australia's Lumos Diagnostics LDX.AX rise as
much as 5.3% to A$0.079, their highest level since Jan. 22
** Stock posts its biggest intraday pct gain since Jan. 24
** The diagnostics solutions provider posts unaudited
revenue of $1.7 mln for Q2 FY24 vs $1.1 mln in Q1 FY24
** LDX stock up 6.8% in January
(Reporting by Roshan Thomas)
((Roshan.Thomas@thomsonreuters.com))
Recent news on Lumos Diagnostics Holdings
See all newsBrief: Lumos Diagnostics Posts FY26 Revenue Of $13.2 Million
Australia's Lumos Diagnostics soars on bagging purchase order for diagnostic test
Brief: Lumos Diagnostics Receives $767,800 Febridx Order From Phase Scientific
Brief: Lumos Diagnostics Signs Exclusive Distribution Agreement For Febridx In Romania
Brief: Lumos Diagnostics Posts FY26 Revenue Rises 6% To $13.2 Million